| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 726718 | 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid | 0.0162638908166157 | 0.3289672 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0162638908166157 | 0.47015631 |
| NSC 732112 | 6-(O-ethyl-2?-diethylamino)-7-(p-methoxycinnamoyl)-3-methyl- benzofuran-2-carboxylic acid ethyl ester hydrochloride | 0.0162638908166157 | 0.046566659 |
| NSC 744231 | Null | 0.0162638908166157 | 0.45161613 |
| NSC 638265 | Null | 0.0163859626459253 | 0.2334485 |
| NSC 736829 | 6-(5-Aminopentyl)-5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]i soquinoline Hydrochloride | 0.0163859626459253 | 0.59772206 |
| NSC 106486 | Formycin B | 0.0171490505199913 | 0.07210167 |
| NSC 146268 | as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- | 0.0171490505199913 | 0.56574717 |
| NSC 201459 | 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- | 0.0171490505199913 | 0.26312864 |
| NSC 295426 | Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) | 0.0171490505199913 | 0.07392329 |